ArticleJournal of Korean medical science2018

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence.

Seong Hee Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.